Ultrasound common hepatic artery denervation (CHA-D) as a novel neuromodulatory strategy for cardiovascular-kidney-metabolic syndrome: first-in-human experience - Poll - MDSpire

Ultrasound common hepatic artery denervation (CHA-D) as a novel neuromodulatory strategy for cardiovascular-kidney-metabolic syndrome: first-in-human experience

  • By

  • Mert Tokcan

  • Franciska Diana Wolter

  • Mathias Hohl

  • Peter Fries

  • Thorsten Kessler

  • Saarraaken Kulenthiran

  • Michael Böhm

  • June 3, 2026

  • 0 min

Share

Original Source(s)

Ultrasound common hepatic artery denervation (CHA-D) as a novel neuromodulatory strategy for cardiovascular-kidney-metabolic syndrome: first-in-human experience

  • by Mert Tokcan, Franciska Diana Wolter, Mathias Hohl, Peter Fries, Thorsten Kessler, Saarraaken Kulenthiran, Michael Böhm

  • June 3, 2026

Related Content

Assessing modifiable risk factors for atrial fibrillation/flutter in the young: a hybrid local-global study

Blood pressure–stratified associations of the atherogenic index of plasma with all-cause mortality: a 10-year rural cohort study in China

Molecular Interplay between hypertension and dyslipidemia in cardiovascular pathogenesis: toward precision-based therapeutic strategies